Venus Concept Inc
NASDAQ:VERO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Venus Concept Inc
Research & Development
Venus Concept Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Venus Concept Inc
NASDAQ:VERO
|
Research & Development
-$5.7m
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Profound Medical Corp
TSX:PRN
|
Research & Development
-$20.6m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-18%
|
|
|
Theralase Technologies Inc
XTSX:TLT
|
Research & Development
-CA$2.6m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
2%
|
|
|
MedMira Inc
XTSX:MIR
|
Research & Development
-CA$965.6k
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
3%
|
|
|
O
|
Ondine Biomedical Inc
LSE:OBI
|
Research & Development
-CA$9.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Conavi Medical Corp
XTSX:CNVI
|
Research & Development
-$13m
|
CAGR 3-Years
34%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
10%
|
|
Venus Concept Inc
Glance View
Venus Concept, Inc. develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related practice enhancement services. The company is headquartered in Toronto, Ontario and currently employs 407 full-time employees. The company went IPO on 2017-10-12. The company develops, commercializes, and sells minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Freedom, Venus Viva, Venus Freeze Plus, Venus Glow, Venus Bliss, Venus Epileve and Venus Viva MD. Its hair restoration division includes NeoGraft, an automated hair restoration system that facilitates the harvesting of follicles during a Follicular unit extraction (FUE) process and the ARTAS and ARTAS iX Robotic Hair Restoration Systems, which harvests follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. The firm operates in the United States, Canada, United Kingdom, Japan, South Korea, Mexico, Argentina, Colombia, Spain, France, Germany, Australia, China, Hong Kong, and Israel.
See Also
What is Venus Concept Inc's Research & Development?
Research & Development
-5.7m
USD
Based on the financial report for Sep 30, 2025, Venus Concept Inc's Research & Development amounts to -5.7m USD.
What is Venus Concept Inc's Research & Development growth rate?
Research & Development CAGR 5Y
10%
Over the last year, the Research & Development growth was 18%. The average annual Research & Development growth rates for Venus Concept Inc have been 16% over the past three years , 10% over the past five years .
